- Home
- BNGO vs PASG Comparison
BNGO vs PASG Comparison
Compare BNGO & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- PASG
- Stock Information
- Founded
- BNGO 2003
- PASG 2017
- Country
- BNGO United States
- PASG United States
- Employees
- BNGO N/A
- PASG N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- BNGO Industrials
- PASG Health Care
- Exchange
- BNGO Nasdaq
- PASG Nasdaq
- Market Cap
- BNGO 24.3M
- PASG 20.3M
- IPO Year
- BNGO 2018
- PASG 2020
- Fundamental
- Price
- BNGO $3.38
- PASG $5.96
- Analyst Decision
- BNGO Buy
- PASG Strong Buy
- Analyst Count
- BNGO 5
- PASG 3
- Target Price
- BNGO $7.33
- PASG $7.67
- AVG Volume (30 Days)
- BNGO 85.5K
- PASG 34.6K
- Earning Date
- BNGO 08-06-2025
- PASG 08-07-2025
- Dividend Yield
- BNGO N/A
- PASG N/A
- EPS Growth
- BNGO N/A
- PASG N/A
- EPS
- BNGO N/A
- PASG N/A
- Revenue
- BNGO $28,464,000.00
- PASG N/A
- Revenue This Year
- BNGO N/A
- PASG N/A
- Revenue Next Year
- BNGO $15.54
- PASG N/A
- P/E Ratio
- BNGO N/A
- PASG N/A
- Revenue Growth
- BNGO N/A
- PASG N/A
- 52 Week Low
- BNGO $2.68
- PASG $5.14
- 52 Week High
- BNGO $41.10
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- BNGO 45.80
- PASG 38.74
- Support Level
- BNGO $3.31
- PASG $7.00
- Resistance Level
- BNGO $3.43
- PASG $9.82
- Average True Range (ATR)
- BNGO 0.14
- PASG 0.99
- MACD
- BNGO 0.03
- PASG -0.16
- Stochastic Oscillator
- BNGO 68.97
- PASG 2.64
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.